Endeavor Health is studying Exact Sciences’ Cancerguard blood test to help see if multi-cancer detection should be deployed widely across hospitals. The five-year study aims to fill gaps in real-world evidence on how these tests perform and how they fit into routine healthcare.
Hackensack Meridian Health launched a clinical trial with Israeli startup SpotitEarly, which is developing a cancer test that combines AI with trained dogs to analyze patients’ breath. The study aims to validate this noninvasive approach alongside traditional screenings, potentially enabling earlier and more accessible cancer detection.
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
Israeli cancer diagnostics startup SpotitEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year.
Providence recently launched a study to help learn more about how health systems can use multi-cancer detection tests in clinical care. Three years ago, Providence became the first health system to use Grail’s Galleri test, which screens patients for more than 50 kinds of cancer.